DENK INGREDIENTS
LIVE

Serial Number

79271037

Owner

DENK PHARMA GmbH & Co. KG

Attorney

Keith A. Weltsch

Filing Date

May 16, 2019

Add to watchlist:

No watchlists yet
View on USPTO

DENK INGREDIENTS Trademark

Serial Number: 79271037 • Registration: 6177146

DENK INGREDIENTS is a trademark filed by DENK PHARMA GmbH & Co. KG on May 16, 2019. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

DENK PHARMA GmbH & Co. KG (3 trademarks)

Prinzregentenstr. 79

Entity Type: 28

Denk Ingredients GmbH

Prinzregentenstraße 79

Entity Type: 99

Trademark Details

Filing Date

May 16, 2019

Registration Date

October 20, 2020

Published for Opposition

August 4, 2020

Goods & Services

Wholesale and retail store services featuring pharmaceutical and chemical preparations used in industry, science, agriculture, horticulture and forestry, especially for use in the foodstuff, food supplement, pharmaceutical and cosmetics industries, artificial sweeteners, pains and diets, plant extracts and plant oils for cosmetic purposes, chemical preparations for pharmaceutical and medical purposes, animal oils and plant oils as well as plant extracts for pharmaceutical and medical purposes, proteins for pharmaceutical and medical purposes, food supplements for pharmaceutical and medical purposes, minerals and vitamins

chemicals for pharmaceutical and medical purposes sold as the components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genito-urinary system and sex hormones, antiinfectives for systemic use, musculo-skeletal system, nervous system and respiratory system, disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy; animal and vegetable oils and plant extracts for pharmaceutical and medical purposes sold as components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genito-urinary system and sex hormones, antiinfectives for systemic use, musculo-skeletal system, nervous system and respiratory system, disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy; protein supplements for pharmaceutical and medical purposes; nutritional supplements for pharmaceutical and medical purposes; all the aforesaid goods being in the form of precursors and intermediates, and being additives and auxiliaries

Chemicals used in industry, science, agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides, in particular for use in the food, dietary supplement, pharmaceutical and cosmetics industries, including in the form of precursors and intermediates, and being additives and auxiliaries; artificial sweeteners

Plant extracts and vegetable oils for cosmetic purposes, including in the form of precursors and intermediates, and being additives and auxiliaries, namely, plant extracts and vegetable oils sold as components of cosmetics

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 18, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 20, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 7, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 6, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 20, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2020 NONP
ASSIGNED TO LIE
Jun 30, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2020 CNSA
CHANGE OF OWNER RECEIVED FROM IB
Jun 25, 2020 DCPN
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2020 TROA
ATTORNEY REVIEW COMPLETED
Jan 13, 2020 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jan 10, 2020 CREV
REFUSAL PROCESSED BY IB
Jan 4, 2020 RFNT
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 27, 2019 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 13, 2019 RFCS
REFUSAL PROCESSED BY MPU
Dec 13, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 19, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 16, 2019 MAFR
ASSIGNED TO EXAMINER
Nov 12, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 2, 2019 REPR